Recap: Oscar Health Q1 Earnings

Oscar Health (NYSE:OSCR) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM. Here’s what…

Oscar Health (NYSE:OSCR) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Oscar Health missed estimated earnings by 260.0%, reporting an EPS of $-0.18 versus an estimate of $-0.05.

Revenue was down $971.29 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 30.26% increase in the share price the next day.

Here’s a look at Oscar Health’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -1.16 -0.73 -0.70 -0.21
EPS Actual -1.05 -0.91 -0.53 -0.36
Revenue Estimate 1.08B 962.16M 960.60M 766.26M
Revenue Actual 995.13M 978.43M 1.02B 972.76M

To track all earnings releases for Oscar Health visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Atara Biotherapeutics Announces Expanded Global Tab-cel Partnership With Pierre Fabre Laboratories And Third Quarter 2023 Financial Results; Cash, Cash Equivalents And Short-Term Investments As Of September 30, 2023, Totaled $102.4M

Pierre Fabre Laboratories to License Commercialization Rights to Tab-cel®, including Regulatory, Manufacturing and Development Activities, in the United States and All Remaining MarketsAtara to Receive Additional

ATRA